SCHEMBL12423716

SCHEMBL12423716

CC(C)NC(=O)c1csc(-c2ccnc(Nc3cccc(C(C)O)c3)n2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STK17A Q9UEE5 2/20 0.46
CAMK2D Q13557 5/20 0.44
IKBKB O14920 1/20 0.43
ABL1 P00519 7/20 0.43
BCR P11274 6/20 0.43
SRC P12931 5/20 0.43
AURKA O14965 1/20 0.41
PRKCA P17252 4/20 0.41
PDGFRB P09619 4/20 0.41
PDGFRA P16234 4/20 0.41
PRKCD Q05655 3/20 0.41
NEK3 P51956 1/20 0.41
LIMK1 P53667 1/20 0.41
NEK5 Q6P3R8 1/20 0.41
MYLK4 Q86YV6 1/20 0.41
MAPK8 P45983 1/20 0.40
PIK3CG P48736 1/20 0.40
GSK3B P49841 1/20 0.40
CAMKK2 Q96RR4 1/20 0.40
JAK2 O60674 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12423714 0.91 CAMK2D (0.52) CAMK2DIKBKBABL1BCRSRC
SCHEMBL12423713 0.89 CAMK2D (0.43) CAMK2DIKBKBABL1BCRSRC
SCHEMBL2198087 0.89 CAMK2D (0.43) CAMK2DIKBKBABL1BCRSRC
SCHEMBL12423725 0.87 CAMK2D (0.44) CAMK2DIKBKBABL1BCRSRC
SCHEMBL12423719 0.86 CAMK2D (0.45) CAMK2DIKBKBABL1BCRSRC
SCHEMBL12423731 0.85 IKBKB (0.52) STK17ACAMK2DIKBKBSRCJAK2
SCHEMBL12423718 0.85 CAMK2D (0.43) CAMK2DIKBKBABL1BCRSRC
SCHEMBL12423724 0.85 ROCK2 (0.43) CAMK2DIKBKBABL1BCRSRC
SCHEMBL12423734 0.85 IKBKB (0.51) STK17ACAMK2DIKBKBSRCJAK2
SCHEMBL12423728 0.84 CAMK2D (0.43) CAMK2DIKBKBABL1BCRSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977481-B2 Pyrimidinyl-thiophene kinase modulators SGX PHARMACEUTICALS, INC. (US) 2011-07-12 US disclosed
US-7977481-B2 Pyrimidinyl-thiophene kinase modulators SGX PHARMACEUTICALS, INC. (US) 2011-07-12 US disclosed
US-20100305128-A1 Pyrimidinyl-Thiophene Kinase Modulators ARNOLD WILLIAM D 2010-12-02 US disclosed
US-20100305128-A1 Pyrimidinyl-Thiophene Kinase Modulators ARNOLD WILLIAM D 2010-12-02 US disclosed
US-7803806-B2 Pyrimidinyl-thiophene kinase modulators SGX PHARMACEUTICALS, INC. (US) 2010-09-28 US disclosed
US-7803806-B2 Pyrimidinyl-thiophene kinase modulators SGX PHARMACEUTICALS, INC. (US) 2010-09-28 US disclosed
US-20070117800-A1 PYRIMIDINYL-THIOPHENE KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2007-05-24 US disclosed
US-20070117800-A1 PYRIMIDINYL-THIOPHENE KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2007-05-24 US disclosed
WO-2007053776-A1 PYRIMIDINYL-THIOPHENE KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2007-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305128-A1 Pyrimidinyl-Thiophene Kinase Modulators MAP3K20, MAP3K6, MAP4K2 STK17A 106/4885CAMK2D 313/4885IKBKB 553/4885
US-20070117800-A1 PYRIMIDINYL-THIOPHENE KINASE MODULATORS MAP3K20, MAP3K6, MAP4K2 STK17A 106/4885CAMK2D 313/4885IKBKB 553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.